HCAT 10-Q: SEC filing
Health Catalyst
Filed with the SEC on · accession 0001636422-26-000125
HCAT filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. Health Catalyst filed a routine SOX Section 302 certification signed by CEO Simeon Kohl as an exhibit to its quarterly report on Form 10-Q. The stock moved -5.7% by the first close after the filing.
Summary of the filing
Health Catalyst filed a routine SOX Section 302 certification signed by CEO Simeon Kohl as an exhibit to its quarterly report on Form 10-Q. The certification confirms the accuracy of the financial statements and the effectiveness of disclosure controls and procedures.
Key details
How HCAT stock reacted
Close before
$1.59
Nov 4, 2026
First close after
-5.66%
$1.50
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for HCAT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for HCAT?
Click hereFrequently asked questions
What did HCAT file with the SEC on Nov 5, 2026?
HCAT filed a 10-Q (SEC filing). Health Catalyst filed a routine SOX Section 302 certification signed by CEO Simeon Kohl as an exhibit to its quarterly report on Form 10-Q. The certification confirms the accuracy of the financial statements and the effectiveness of disclosure controls and procedures.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did HCAT stock react to this filing?
HCAT closed at $1.59 before the filing and $1.50 on Nov 5, 2026 (-5.66%).
Other HCAT SEC filings
- 8-K · Guidance raiseNov 5, 2026
- 8-K · Board changeSep 14, 2026
- 8-K · Ceo changeSep 8, 2026
- 8-K · Guidance raiseAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Board changeJul 20, 2026
- 144 · Insider sale plannedJun 10, 2026
- 8-K · AcquisitionJun 4, 2026
- DEF 14A · Board changeJun 3, 2026
- 144 · Insider sale plannedJun 1, 2026
Get alerts when HCAT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days